Here are five things to know.
1. The global surgical implant company’s worldwide revenues for the first quarter of 2018 were $69.9 million, comparable with first quarter 2017.
2. Revenues were driven by growth in the OEM and International business lines as well as RTI Surgical’s acquisition of spine-focused device company Zyga Technology.
3. Growth was partially offset by declines in the company’s Sports and Spine lines. Gross profit for the first quarter of 2018 was $33.7 million, or 48.2 percent of revenues, compared to $35.8 million, or 51.2 percent of revenues, in first quarter 2017.
4. Net loss applicable to common shares was $1.9 million in first quarter 2018, or $0.03, compared to a net loss applicable to common shares of $2.8 million in the same period last year.
5. RTI Surgical expects full year revenues between $280 million and $290 million.
More articles on devices and implants:
NuVasive’s CEO is preparing for more outpatient spine, less desire for robots: 6 key quotes
Paradigm Spine gets pre-market approval for disposable instrument kit: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.